Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith E Clement

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
JAMIA Open|August 1, 2020
Machine learning for early detection of sepsis: an internal and temporal validation studyArmando D Bedoya, Joseph Futoma, Meredith E Clement, et al.
The American Journal of Cardiology|August 3, 2019
Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency VirusFawaz Alenezi, Gerald S Bloomfield, Nwora Lance Okeke, et al.
JMIR Research Protocols|March 21, 2023
A Multicomponent Intervention to Train and Support Family Medicine Providers to Promote Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in the Deep South: Protocol for the PrEP-Pro StudyOluwaseyi O Isehunwa, Samantha V Hill, Alex Tobias Menninger, et al.
Annals of Internal Medicine|January 31, 2022
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness AnalysisAnne M Neilan, Raphael J Landovitz, Mylinh H Le, et al.
Open Forum Infectious Diseases|September 5, 2020
Clinical Characteristics and Outcomes Based on Race of Hospitalized Patients With COVID-19 in a New Orleans CohortVictoria Silver, Andrew G Chapple, Allison H Feibus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2024
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083Meredith E Clement, Brett Hanscom, Daniel Haines, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
Plos One|September 29, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
The Lancet. HIV|November 12, 2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trialRaphael J Landovitz, Brett S Hanscom, Meredith E Clement, et al.
JAMA|June 3, 2021
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical TrialMyron S Cohen, Ajay Nirula, Mark J Mulligan, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
JAMIA Open|August 1, 2020
Machine learning for early detection of sepsis: an internal and temporal validation studyArmando D Bedoya, Joseph Futoma, Meredith E Clement, et al.
The American Journal of Cardiology|August 3, 2019
Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency VirusFawaz Alenezi, Gerald S Bloomfield, Nwora Lance Okeke, et al.
JMIR Research Protocols|March 21, 2023
A Multicomponent Intervention to Train and Support Family Medicine Providers to Promote Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in the Deep South: Protocol for the PrEP-Pro StudyOluwaseyi O Isehunwa, Samantha V Hill, Alex Tobias Menninger, et al.
Annals of Internal Medicine|January 31, 2022
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness AnalysisAnne M Neilan, Raphael J Landovitz, Mylinh H Le, et al.
Open Forum Infectious Diseases|September 5, 2020
Clinical Characteristics and Outcomes Based on Race of Hospitalized Patients With COVID-19 in a New Orleans CohortVictoria Silver, Andrew G Chapple, Allison H Feibus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2024
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083Meredith E Clement, Brett Hanscom, Daniel Haines, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
Plos One|September 29, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
The Lancet. HIV|November 12, 2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trialRaphael J Landovitz, Brett S Hanscom, Meredith E Clement, et al.
JAMA|June 3, 2021
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical TrialMyron S Cohen, Ajay Nirula, Mark J Mulligan, et al.
Pageof 5